JMP Securities


JMP Analysts Mixed on Palo Alto Networks Inc (PANW) and Canadian Solar Inc. (CSIQ) Following Earnings Releases

This has been a rough week for investors of Palo Alto Networks Inc (NYSE:PANW) and Canadian Solar Inc.(NASDAQ:CSIQ) after the companies released their quarterly results that failed …

JMP Analyst Bearish on Oracle Corporation (ORCL) Ahead of Earnings

In a research report issued Wednesday, JMP Securities analyst Patrick Walravens reiterated an Underperform rating on shares of Oracle Corporation (NYSE:ORCL) with a price target …

JMP Sees 10% Chance of Approval for Sarepta Therapeutics Inc’s (SRPT) Eteplirsen In Light of Key Drug Critic Departure

In a research note issued Wednesday, JMP Securities analyst Liisa Bayko reiterated an Underperform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) with a $10 …

JMP Securities Remains Sidelined on OvaScience Inc (OVAS) Following 2Q:16 Update

OvaScience Inc (NASDAQ:OVAS) just reported second-quarter earnings, but for JMP Securities analyst Michael King, the true assessment of OVAS as an investing opportunity …

JMP Analyst Bullish on ACADIA Pharmaceuticals Inc. (ACAD) Following Q2:16 Update; Finds NUPLAZID on Track

JMP Securities analyst Jason Butler weighs in on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after the biotech company reported second-quarter financial results that …

JMP Securities Bullish on Cytokinetics, Inc. (CYTK) Following 2Q Update; Sees Key Catalysts on Track

In light of Cytokinetics, Inc.’s (NASDAQ:CYTK) second-quarter update, JMP Securities analyst Jason Butler remains bullish for the biotech company’s pipeline drug-paved road ahead.

JMP Securities Positive for Amazon.com, Inc. (AMZN) Following Strong Accelerated Revenue Growth in Q2

JMP Securities analyst Ronald Josey reiterates a Buy rating on shares of Amazon.com, Inc.

JMP Securities Chimes In on Sarepta Therapeutics Inc (SRPT) Following 2Q Update; Awaits FDA Decision on Eteplirsen

JMP Securities analyst Liisa Bayko was out with a research note on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), after the biotech company released uneventful second-quarter results …

JMP Analyst Discusses What To Look For In Yahoo! Inc.’s (YHOO) Earnings Today

Analyst Ronald Josey of JMP Securities shared his expectations for Yahoo! Inc.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts